<?xml version="1.0" encoding="UTF-8"?>
<STUDY_SET xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <STUDY center_name="BioProject" alias="PRJNA771240" accession="SRP341530">
    <IDENTIFIERS>
      <PRIMARY_ID>SRP341530</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioProject" label="primary">PRJNA771240</EXTERNAL_ID>
    </IDENTIFIERS>
    <DESCRIPTOR>
      <STUDY_TITLE>Identification of HLA-DR as an antigen for a Vdelta1-positive gamma-delta TCR</STUDY_TITLE>
      <STUDY_TYPE existing_study_type="Other"/>
      <STUDY_ABSTRACT>We aimed to identify new ligands for Vdelta1-positive gamma-delta TCRs. To this end, we performed reporter cell screenings and identified Vgamma3 Vdelta1 positive gamma-delta TCR recognizing Raji B cell lymphoma cells. With soluble ectodomains of the respective TCR binding to Raji cells, we were able to further perform a genome-wide CRISPR-Cas9 knock-out screening and selected cells that lost binding to soluble version of the gamma-delta TCR of interest. The contained gRNAs were amplified via PCR and sequenced via Illumina NGS. This led to the identification of HLA-DR as the cognate antigen. Via gene-specific PCR amplification and subsequent Illlumina NGS, we identified the HLA-DR haplotype of Raji cells.The used Human Brunello CRISPR knockout pooled library was a gift from David Root and John Doench (Addgene #73178).</STUDY_ABSTRACT>
      <CENTER_PROJECT_NAME>Homo sapiens</CENTER_PROJECT_NAME>
    </DESCRIPTOR>
  </STUDY>
</STUDY_SET>
